Alexandra Rogers, MD
Urology · Lafayette, CONPI 1093954497
Payments from drug & device makers
Across 501 payments — averaging $1080.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$373K
- Medtronic$65K
- Sumitomo Pharma America, Inc.$40K
- Axonics, Inc.$38K
- Urovant Sciences Inc$23K
- C. R. Bard, Inc. & Subsidiaries$393
- plus $2K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valencia Technologies Corporation | 53 | $373,380 |
| Medtronic(2 entities) | 175 | $64,530 |
| Sumitomo Pharma America, Inc. | 63 | $40,429 |
| Axonics, Inc. | 111 | $37,873 |
| Urovant Sciences Inc | 25 | $22,555 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $393 |
| BD | 1 | $380 |
| AbbVie(2 entities) | 11 | $270 |
| Boston Scientific | 5 | $202 |
| Astellas Pharma US Inc | 9 | $194 |
| Procept Biorobotics Corporation | 1 | $135 |
| Coloplast | 4 | $132 |
| Teleflex LLC | 4 | $131 |
| Biotissue Holdings Inc. | 1 | $122 |
| Ferring Pharmaceuticals Inc. | 7 | $111 |
| Pfizer | 6 | $102 |
| Innovation Technologies Inc | 2 | $58 |
| Bayer | 1 | $57 |
| Neotract Inc. | 3 | $54 |
| Olympus America Inc. | 1 | $44 |
| Revance Therapeutics, Inc. | 1 | $37 |
| Johnson & Johnson(2 entities) | 2 | $31 |
| Tolmar Pharmaceuticals, Inc. | 1 | $25 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Sagent Pharmaceuticals | 1 | $23 |
| Photocure Inc | 1 | $21 |
| Palette Life Sciences, Inc. | 1 | $20 |
| Dentsply IH Inc. | 1 | $20 |
| Dentsply IH AB | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Mission Pharmacal Company | 1 | $15 |
| Foundation Medicine, Inc. | 1 | $14 |
| Cook Medical LLC | 1 | $11 |
How this compares
$541,442 in reported general payments places this provider in the 95th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Lafayette
- Julio ChongLafayette$36K
- David CahnGolden$12.1M
- Lawrence KarshDenver$9.7M
- Derek ZukoskyGolden$442K
- Paul MaroniAurora$234K
- James McBrideDurango$234K
- James FagelsonLittleton$229K
- Damian SorceParker$224K
- Michael FerrandinoWestminster$194K
- Brian FlynnAurora$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.